Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q3 2021 vs. Q2 2021

How the institutions holding IMMUTEP Ltd changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of IMMP: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders28280
Shares8.51M7.98M−531.5K (−6.2%)
Value$32.9M$30.9M−$2.06M (−6.3%)

New holders (6)

Institutions that held IMMUTEP Ltd at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to IMMP in Q3 2021
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP62,913$243.0K0.00%
State Street Corp52,100$202.0K0.00%
Belvedere Trading LLC34,472$143.0K0.04%
Toroso Investments, LLC23,308$90.0K0.00%
Beirne Wealth Consulting Services, LLC10,000$39.0K0.02%
Lindbrook Capital, LLC10,000$39.0K0.01%

Sold out (6)

Institutions that held IMMUTEP Ltd at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of IMMP in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Marshall Wace, LLP165,768$642.0K
Goldman Sachs Group Inc36,282$140.0K
Truist Financial Corp15,000$58.0K
Citigroup Inc5,000$19.0K
Tower Research Capital LLC (TRC)1,218$5.00K
FMR LLC1$0